The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia.
Ross L Levine, Marc Loriaux, Brian J P Huntly, Mignon L Loh, Miroslav Beran, Eric Stoffregen, Roland Berger, Jennifer J Clark, Stephanie G Willis, Kim T Nguyen, Nikki J Flores, Elihu Estey, Norbert Gattermann, Scott Armstrong, A Thomas Look, James D Griffin, Olivier A Bernard, Michael C Heinrich, D Gary Gilliland, Brian Druker, Michael W N Deininger
Blood 2005;106(10):3377-9